Connect with us

Hi, what are you looking for?

Saturday, Apr 19, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Parent Company starts trading on the NEO stock exchange in Canadian currency
Parent Company starts trading on the NEO stock exchange in Canadian currency
Photo via the Parent Company.

Cannabis

The Parent Company starts trading on the NEO stock exchange in Canadian currency

New currency conversion will allow investors in Canada to access securities in Canadian dollars

TPCO Holding Corp. (NEO: GRAM.U) (OTCQX: GRAMF) otherwise known as the Parent Company will soon be allowing investors to purchase shares with Canadian dollars.

On Friday, the company announced that it would begin trading on the NEO Stock Exchange in Canadian currency on October 7 this year with the revised symbol GRAM.

The company says that its NEO-listed warrants will continue to trade under the symbol GRAM.WT.U.

Read more: Global cannabis market to reach US$82.3 billion by 2027: ReportLinker

Read more: Khalifa Kush makes Florida debut at Trulieve locations

The Parent Company also says that its OTCQX securities will continue trading in U.S dollars with the GRAMF ticker for the convenience of investors residing in the United States.

This new company development will enable Canadian and American investors to trade securities from TPCO with their domestic currency.

TPCO is a cannabis company with eleven retail outlets, four delivery hubs and a brand portfolio featuring Monogram by renowned hip-hop artist JAY-Z and Mirayo by the famous guitarist, Santana.

The company also recently launched the RCVRY cannabis brand in California.

Company stock dropped by 0.83 per cent today to US$0.60 on the OTC exchange and increased by 3.39 per cent to US$0.61 on the NEO exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cannabis

Its construction will cost US$25 million and it will employ up to 100 Kentuckians

Cannabis

The latest data from Health Canada shows a 98% year-over-year spike

Cannabis

People didn't seem to think that the product was exceptional enough for the exceptionally high price tag

Health & Wellness

The company focuses on oral delivery of biologics, and may be benefiting from investor speculation